医疗保健和生命科学领域自然语言处理市场—全球产业规模、份额、趋势、机会和预测：按组件、NLP 类型、部署模式、最终用户、地区和竞争格局划分，2021-2031 年

全球医疗保健和生命科学领域的自然语言处理市场预计将从 2025 年的 31.7 亿美元增长到 2031 年的 53.4 亿美元，复合年增长率为 9.09%。

此领域利用计算演算法，从电子健康记录、医疗记录和科学文献等非结构化资料来源解读、理解并产生人类语言。推动市场成长的根本动力源自于以下两方面：一是迫切需要透过自动化文件来减轻临床医师的职业倦怠；二是企业需要从庞大的医学文本库中提取可操作的洞见。这种结构性需求是市场扩张的核心驱动力，而非短暂的科技趋势。根据医疗集团管理协会（Medical Group Management Association）预测，到2024年，“59%的医疗集团领导者将把速记和文件工具视为他们面临的首要人工智慧挑战。”

然而，市场在资料隐私和监管合规方面面临许多重大障碍。在满足严格法律标准的同时保护敏感的患者资讯是一项复杂的任务，它会带来巨大的责任风险和互通性挑战。这些障碍可能会阻碍自然语言处理技术在医疗保健领域的广泛应用。

市场驱动因素

生成式人工智慧和大规模语言模型的进步是目前推动全球医疗保健和生命科学自然语言处理（NLP）市场变革的最重要力量。与传统NLP不同，这些技术能够产生更高级的临床文件并自动总结患者病史。随着医疗服务提供者寻求利用这些工具来改善诊断支援和优化工作流程，这项技术飞跃正在推动医疗机构的快速应用。根据美国医学会（AMA）于2025年2月进行的增强智能调查，到2024年，66%的医生将在实践中使用人工智慧，几乎是前一年的两倍。这一增长是由专业人士态度的转变所推动的。正如VatorNews在2025年2月发表的报导《AMA：到2024年，使用人工智慧的医生人数几乎翻一番》中所述，36%的医生表示对人工智慧感到兴奋多于担忧，这表明市场对这些先进功能的需求强劲。

提高营运效率和控制医疗成本是第二个关键驱动因素，它直接应对了医护人员倦怠和行政负担过重等结构性挑战。随着医疗机构面临财务压力，它们越来越多地采用自然语言处理 (NLP) 解决方案来自动化医疗编码、收入週期管理和即时文件等劳动密集型任务。这些工具减轻了医护人员的认知负担，使他们能够专注于患者照护而非资料输入。根据 Elsevier 于 2025 年 7 月发布的《未来临床医生 2025》报告，57% 的临床医生认为临床人工智慧工具可以节省他们的时间。透过简化行政工作流程，NLP 应用不仅提高了营运效率，还有助于确保医疗服务系统在日益资料密集的环境中永续性。

市场挑战

严格的资料隐私保护和监管合规要求对全球医疗保健和生命科学领域的自然语言处理（NLP）市场扩张构成了重大障碍。医疗机构在严格的法律体制下运营，这些框架要求绝对保护病患隐私。为了有效运行，NLP系统需要存取大量的非结构化临床记录数据，这本身就存在洩露个人识别资讯（PII）的风险。资料外洩可能带来的高昂代价和巨额监管罚款迫使医疗机构采取规避风险的策略，从而显着延缓了这些技术的采购和整合。

这种营运上的谨慎态度正在阻碍市场成长，因为决策者优先考虑的是规避责任而非技术能力。对违规的担忧使得医疗服务提供者不愿在其网路中推广自然语言处理（NLP）解决方案，通常将计划限制在小规模、孤立的试点阶段。这种犹豫不决也体现在近期关于采用标准的行业调查结果中：根据美国医学会2024年的调查，「87%的医生认为数据隐私保障是推动人工智慧工具普及的最重要因素。」这一数据凸显了行业内持续存在的合规性问题仍在阻碍着NLP解决方案的广泛商业化。

市场趋势

利用自然语言处理（NLP）加速药物研发和识别生物标记物，正将市场关注点从行政自动化转向科学研究。製药公司正利用演算法预测分子交互作用，并从海量的科学文献和基因组数据中识别潜在的治疗标靶。这种转变使研究人员能够缩短药物研发的早期阶段，并显着减少将新治疗方法推进到临床试验所需的时间。根据英伟达（NVIDIA）于2025年7月发布的《医疗保健和生命科学领域人工智慧现状：2025年趋势》调查，59%的製药和生物技术专业人士表示，他们采用人工智慧的主要目的是进行药物研发，这凸显了计算生物学在该行业中的重要性。

透过自动化患者配对简化临床试验参与者招募流程，正在消除生命科学研究中一个关键的参与者招募瓶颈。自然语言处理 (NLP) 引擎正越来越多地整合到临床工作流程中，用于解析非结构化的电子健康记录和病理报告，从而根据复杂的筛选标准自动识别合格的候选人。这项功能确保了患者群的准确性，同时最大限度地减少了招募失败而造成的代价高昂的延误。这一趋势正在推动其广泛应用；根据 Medidata 于 2025 年 10 月发布的报告《人工智慧在临床试验中的现状与未来》，83% 在临床试验中使用人工智慧的公司正在使用该技术，特别是用于患者群体和队列识别。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章：全球医疗保健与生命科学自然语言处理市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按组件（解决方案、服务）
  • 依自然语言处理类型（基于规则的自然语言处理、统计自然语言处理、混合自然语言处理）
  • 依部署类型（本机部署、云端部署）
  • 依最终使用者（公共卫生/政府机构、医疗设备、健康保险、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美医疗保健与生命科学自然语言处理市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲医疗保健与生命科学自然语言处理市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区医疗保健与生命科学自然语言处理市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲医疗保健和生命科学领域自然语言处理市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲医疗保健与生命科学自然语言处理市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

13. 全球医疗保健与生命科学领域自然语言处理市场：SWOT 分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• SAS Institute Inc.
• IBM Corporation
• Microsoft Corporation
• Google LLC
• IQVIA Inc
• Oracle Corporation
• Inovalon
• Dolbey Systems, Inc.
• Averbis GmbH

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global NLP in Healthcare & Life Sciences Market is projected to expand from USD 3.17 Billion in 2025 to USD 5.34 Billion by 2031, registering a CAGR of 9.09%. This field involves the use of computational algorithms to interpret, understand, and generate human language from unstructured sources like electronic health records, clinical notes, and scientific literature. The market's fundamental growth is driven by the critical need to alleviate clinician burnout through automated documentation and the operational requirement to extract actionable insights from massive repositories of medical text. These structural necessities distinguish the market's core expansion from temporary technological trends. According to the 'Medical Group Management Association', in '2024', '59% of medical group leaders identified scribing and documentation tools as their top artificial intelligence priority'.

However, the market faces significant hurdles regarding data privacy and the complexity of regulatory compliance. The intricate task of securing sensitive patient information while satisfying rigorous legal standards introduces major liability risks and interoperability challenges. These obstacles threaten to impede the widespread scaling of NLP technologies across the healthcare sector.

Market Driver

Advancements in Generative AI and Large Language Models constitute the most transformative force currently reshaping the Global NLP in Healthcare & Life Sciences Market. Unlike traditional NLP, these technologies allow for the sophisticated generation of clinical documentation and automated summarization of patient histories. This technological leap has sparked rapid adoption across medical practices as providers aim to leverage these tools for improved diagnostic support and workflow optimization. According to the American Medical Association's 'Augmented Intelligence Research' survey from February 2025, 66% of physicians reported using AI in their practices in 2024, a figure that nearly doubled from the previous year. This surge is supported by changing professional sentiment; as noted by VatorNews in February 2025, in the 'AMA: physicians using AI nearly doubled in 2024' article, 36% of physicians reported feeling more excited than concerned about AI, indicating a strong market appetite for these advanced capabilities.

The imperative for operational efficiency and healthcare cost containment serves as the second critical driver, directly addressing the systemic challenges of clinician burnout and administrative overload. As healthcare organizations confront mounting financial pressures, NLP solutions are increasingly deployed to automate labor-intensive tasks such as medical coding, revenue cycle management, and real-time documentation. These tools reduce the cognitive load on practitioners, allowing them to redirect their focus from data entry to patient care. According to the 'Clinician of the Future 2025' report by Elsevier in July 2025, 57% of clinicians perceive clinical AI tools as saving them time. By streamlining administrative workflows, NLP applications not only improve operational margins but also help ensure the sustainability of healthcare delivery systems in an increasingly data-dense environment.

Market Challenge

The strict enforcement of data privacy and regulatory compliance acts as a substantial barrier to the expansion of the Global NLP in Healthcare and Life Sciences Market. Healthcare organizations function under rigorous legal frameworks that mandate the absolute protection of patient confidentiality. Because NLP systems require access to vast datasets of unstructured clinical notes and records to operate effectively, there is an inherent risk of exposing Personally Identifiable Information (PII). The potential for costly data breaches and heavy regulatory fines compels institutions to adopt a risk-averse approach, significantly slowing the procurement and integration of these technologies.

This operational caution creates a bottleneck for market growth, as decision-makers prioritize liability protection over technological capabilities. The fear of non-compliance limits the willingness of providers to scale NLP solutions across their networks, often confining projects to small, isolated pilots. This reluctance is reflected in recent industry findings regarding adoption criteria. According to the 'American Medical Association', in '2024', '87% of physicians identified data privacy assurances as a top attribute required to advance the adoption of artificial intelligence tools'. This statistic underscores that widespread commercialization remains hindered by deep-seated compliance anxieties within the sector.

Market Trends

The utilization of NLP to accelerate drug discovery and biomarker identification is shifting the market focus from administrative automation to scientific research. Pharmaceutical companies are deploying algorithms to mine vast repositories of scientific literature and genomic data to predict molecular interactions and identify potential therapeutic targets. This transition enables researchers to compress the initial stages of drug development, significantly reducing the time required to bring new therapies to clinical testing. According to NVIDIA, July 2025, in the 'State of AI in Healthcare and Life Sciences: 2025 Trends' survey, 59% of pharma and biotech professionals identified drug discovery as their primary AI goal, underscoring the sector's prioritization of computational biology.

The enhancement of clinical trial recruitment via automated patient matching is addressing the critical bottleneck of participant enrollment in life sciences research. NLP engines are increasingly integrated into clinical workflows to parse unstructured electronic health records and pathology reports, automatically identifying eligible candidates based on complex inclusion criteria. This capability ensures accurate patient cohorts while minimizing costly delays associated with recruitment failures. This trend is driving substantial adoption; according to Medidata, October 2025, in the 'The State of AI in Clinical Trials: Today and Tomorrow' report, 83% of companies using AI in clinical trials are now leveraging the technology specifically for patient population and cohort identification.

Key Market Players

• SAS Institute Inc.
• IBM Corporation
• Microsoft Corporation
• Google LLC
• IQVIA Inc
• Oracle Corporation
• Inovalon
• Dolbey Systems, Inc.
• Averbis GmbH

Report Scope

In this report, the Global NLP in Healthcare & Life Sciences Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

NLP in Healthcare & Life Sciences Market, By Component

• Solutions
• Services

NLP in Healthcare & Life Sciences Market, By NLP Type

• Rule-Based Natural Language Processing
• Statistical Natural Language Processing
• Hybrid Natural Language Processing

NLP in Healthcare & Life Sciences Market, By Deployment Mode

• On-premises
• Cloud

NLP in Healthcare & Life Sciences Market, By End User

• Public Health & Government Agencies
• Medical Devices
• Healthcare Insurance
• Others

NLP in Healthcare & Life Sciences Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global NLP in Healthcare & Life Sciences Market.

Available Customizations:

Global NLP in Healthcare & Life Sciences Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global NLP in Healthcare & Life Sciences Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Solutions, Services)
  • 5.2.2. By NLP Type (Rule-Based Natural Language Processing, Statistical Natural Language Processing, Hybrid Natural Language Processing)
  • 5.2.3. By Deployment Mode (On-premises, Cloud)
  • 5.2.4. By End User (Public Health & Government Agencies, Medical Devices, Healthcare Insurance, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America NLP in Healthcare & Life Sciences Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By NLP Type
  • 6.2.3. By Deployment Mode
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States NLP in Healthcare & Life Sciences Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By NLP Type
      • 6.3.1.2.3. By Deployment Mode
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada NLP in Healthcare & Life Sciences Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By NLP Type
      • 6.3.2.2.3. By Deployment Mode
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico NLP in Healthcare & Life Sciences Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By NLP Type
      • 6.3.3.2.3. By Deployment Mode
      • 6.3.3.2.4. By End User

7. Europe NLP in Healthcare & Life Sciences Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By NLP Type
  • 7.2.3. By Deployment Mode
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany NLP in Healthcare & Life Sciences Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By NLP Type
      • 7.3.1.2.3. By Deployment Mode
      • 7.3.1.2.4. By End User
  • 7.3.2. France NLP in Healthcare & Life Sciences Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By NLP Type
      • 7.3.2.2.3. By Deployment Mode
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom NLP in Healthcare & Life Sciences Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By NLP Type
      • 7.3.3.2.3. By Deployment Mode
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy NLP in Healthcare & Life Sciences Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By NLP Type
      • 7.3.4.2.3. By Deployment Mode
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain NLP in Healthcare & Life Sciences Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By NLP Type
      • 7.3.5.2.3. By Deployment Mode
      • 7.3.5.2.4. By End User

8. Asia Pacific NLP in Healthcare & Life Sciences Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By NLP Type
  • 8.2.3. By Deployment Mode
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China NLP in Healthcare & Life Sciences Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By NLP Type
      • 8.3.1.2.3. By Deployment Mode
      • 8.3.1.2.4. By End User
  • 8.3.2. India NLP in Healthcare & Life Sciences Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By NLP Type
      • 8.3.2.2.3. By Deployment Mode
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan NLP in Healthcare & Life Sciences Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By NLP Type
      • 8.3.3.2.3. By Deployment Mode
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea NLP in Healthcare & Life Sciences Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By NLP Type
      • 8.3.4.2.3. By Deployment Mode
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia NLP in Healthcare & Life Sciences Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By NLP Type
      • 8.3.5.2.3. By Deployment Mode
      • 8.3.5.2.4. By End User

9. Middle East & Africa NLP in Healthcare & Life Sciences Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By NLP Type
  • 9.2.3. By Deployment Mode
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia NLP in Healthcare & Life Sciences Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By NLP Type
      • 9.3.1.2.3. By Deployment Mode
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE NLP in Healthcare & Life Sciences Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By NLP Type
      • 9.3.2.2.3. By Deployment Mode
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa NLP in Healthcare & Life Sciences Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By NLP Type
      • 9.3.3.2.3. By Deployment Mode
      • 9.3.3.2.4. By End User

10. South America NLP in Healthcare & Life Sciences Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By NLP Type
  • 10.2.3. By Deployment Mode
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil NLP in Healthcare & Life Sciences Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By NLP Type
      • 10.3.1.2.3. By Deployment Mode
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia NLP in Healthcare & Life Sciences Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By NLP Type
      • 10.3.2.2.3. By Deployment Mode
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina NLP in Healthcare & Life Sciences Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By NLP Type
      • 10.3.3.2.3. By Deployment Mode
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global NLP in Healthcare & Life Sciences Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. SAS Institute Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. IBM Corporation
• 15.3. Microsoft Corporation
• 15.4. Google LLC
• 15.5. IQVIA Inc
• 15.6. Oracle Corporation
• 15.7. Inovalon
• 15.8. Dolbey Systems, Inc.
• 15.9. Averbis GmbH

16. Strategic Recommendations

17. About Us & Disclaimer